CORD-19:22616110b79baaf4c9d23f130a9ee35c64d991f7 / 383442-383607
Annnotations
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T503","span":{"begin":0,"end":165},"obj":"Sentence"}],"text":"There was a correlation between ESBL (+) production and resistant to many antibiotics that are generally used for ampiric treatment (p \u003c 0,05, Pearson correlation r:"}
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T19948","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"There was a correlation between ESBL (+) production and resistant to many antibiotics that are generally used for ampiric treatment (p \u003c 0,05, Pearson correlation r:"}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2119","span":{"begin":6,"end":9},"obj":"Disease"}],"attributes":[{"id":"A2119","pred":"mondo_id","subj":"T2119","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"There was a correlation between ESBL (+) production and resistant to many antibiotics that are generally used for ampiric treatment (p \u003c 0,05, Pearson correlation r:"}